keyword
https://read.qxmd.com/read/38116770/the-endocannabinoid-system-and-its-relationship-to-human-reproduction
#41
REVIEW
A Pařízek, J Suchopár, Z Laštůvka, M Alblová, M Hill, M Dušková
The endocannabinoid system is among the most important regulators of human reproduction. It already applies at the level of the sperm and the egg, plays an important role in the fertilization of the egg, its implantation, regulates the function of the placenta and participates in childbirth. The aim of this work is to summarize the knowledge accumulated so far and to show that the endocannabinoid system must be perfectly regulated in order to maintain a physiological pregnancy from implantation to delivery...
December 17, 2023: Physiological Research
https://read.qxmd.com/read/38113964/activation-of-the-cannabinoid-type-2-cb2-receptor-improves-cardiac-contractile-performance-in-fish-brycon-amazonicus
#42
JOURNAL ARTICLE
Yan Costa Gonçalves, Karina Carla de Francisco Campos, Eliton da Silva Vasconcelos, Beatriz Micucci D'Almeida Eça, Francisco Tadeu Rantin, Ana Lúcia Kalinin, Diana Amaral Monteiro
In addition to their well-known classical effects, cannabinoid CB1 and CB2 receptors have also been involvement in both deleterious and protective actions on the heart under various pathological conditions. While the potential therapeutic applications of the endocannabinoid system in the context of cardiovascular function are indeed a viable prospect, significant debate exists within the literature regarding whether CB1, CB2, or a combination of both receptors exert a favorable influence on cardiac function...
December 17, 2023: Comparative Biochemistry and Physiology. Toxicology & Pharmacology: CBP
https://read.qxmd.com/read/38100640/investigation-of-the-cytotoxicity-induced-by-cannabinoids-on-human-ovarian-carcinoma-cells
#43
JOURNAL ARTICLE
Kartheek Sooda, Simon J Allison, Farideh A Javid
Cannabinoids have been shown to induce anti-tumor activity in a variety of carcinoma cells such as breast, prostate, and brain. The aim of the present study is to investigate the anti-tumor activity of cannabinoids, CBD (cannbidiol), and CBG (cannabigerol) in ovarian carcinoma cells sensitive and resistant to chemotherapeutic drugs. Sensitive A2780 cells and resistant A2780/CP70 carcinoma cells and non-carcinoma cells were exposed to varying concentrations of CBD, CBG, carboplatin or CB1 and CB2 receptor antagonists, AM251 and AM630, respectively, alone or in combination, at different exposure times and cytotoxicity was measured by MTT assay...
December 2023: Pharmacology Research & Perspectives
https://read.qxmd.com/read/38074691/cannabinoids-and-the-endocannabinoid-system-in-immunotherapy-helpful-or-harmful
#44
REVIEW
Arailym Sarsembayeva, Rudolf Schicho
Numerous studies in various cancer models have demonstrated that ingredients of cannabis can influence tumor growth through the endocannabinoid system (ECS), a network of molecules (mediators, receptors, transporters, enzymes) that maintains homeostasis and protection in many tissues. The main constituents of the ECS are the classical cannabinoid (CB) receptors, such as CB1 and CB2 , their endogenous ligands (endocannabinoids), and the endocannabinoids' synthesizing and degrading enzymes. The role of the ECS in cancer is still unclear and its effects often depend on the tumor entity and the expression levels of CB receptors...
2023: Frontiers in Oncology
https://read.qxmd.com/read/38069049/neuroprotection-and-beyond-the-central-role-of-cb1-and-cb2-receptors-in-stroke-recovery
#45
REVIEW
Bashir Bietar, Sophie Tanner, Christian Lehmann
The endocannabinoid system, with its intricate presence in numerous cells, tissues, and organs, offers a compelling avenue for therapeutic interventions. Central to this system are the cannabinoid receptors 1 and 2 (CB1R and CB2R), whose ubiquity can introduce complexities in targeted treatments due to their wide-ranging physiological influence. Injuries to the central nervous system (CNS), including strokes and traumatic brain injuries, induce localized pro-inflammatory immune responses, termed neuroinflammation...
November 24, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/38059783/cannabidiol-inhibits-ige-mediated-mast-cell-degranulation-and-anaphylaxis-in-mice
#46
JOURNAL ARTICLE
Xiaohui Yang, Dohyeon Lee, Hyun-Woo Kim, Byung-Hyun Park, Changjin Lim, Eun Ju Bae
SCOPE: Cannabidiol (CBD), the most abundant non-psychoactive constituent of the plant Cannabis sativa, is known to possess immune modulatory properties. This study investigates the effects of CBD on mast cell degranulation in human and mouse primary mast cells and passive cutaneous anaphylaxis in mice. METHODS AND RESULTS: Mouse bone marrow-derived mast cells and human cord-blood derived mast cells are generated. CBD suppressed antigen-stimulated mast cell degranulation in a concentration-dependent manner...
December 7, 2023: Molecular Nutrition & Food Research
https://read.qxmd.com/read/38059442/effects-of-cannabinoid-agonists-and-antagonists-in-male-rats-discriminating-the-synthetic-cannabinoid-am2201
#47
JOURNAL ARTICLE
Dalal AlKhelb, Emily L Burke, Alexander Zvonok, Christos Iliopoulos-Tsoutsouvas, Markos-Orestis Georgiadis, Shan Jiang, Thanh C Ho, Spyros P Nikas, Alexandros Makriyannis, Rajeev I Desai
The synthetic forms of delta-9-tetrahydrocannabinol (Δ9 -THC), dronabinol or nabilone, have been approved to treat several indications. However, due to safety concerns their clinical utility remains limited. Consequently, there is a need for developing cannabinoid (CB) ligands that display better behavioral pharmacological profiles than Δ9 -THC. Here, we utilized drug discrimination methods to compare the interoceptive effects of CB ligands that vary in potency, efficacy, and selectivity at the CB receptors, including two ligands, AM411 and AM4089, that show CB1 partial agonist-like actions in vitro...
December 5, 2023: European Journal of Pharmacology
https://read.qxmd.com/read/38052772/a-monoacylglycerol-lipase-inhibitor-showing-therapeutic-efficacy-in-mice-without-central-side-effects-or-dependence
#48
JOURNAL ARTICLE
Ming Jiang, Mirjam C W Huizenga, Jonah L Wirt, Janos Paloczi, Avand Amedi, Richard J B H N van den Berg, Joerg Benz, Ludovic Collin, Hui Deng, Xinyu Di, Wouter F Driever, Bogdan I Florea, Uwe Grether, Antonius P A Janssen, Thomas Hankemeier, Laura H Heitman, Tsang-Wai Lam, Florian Mohr, Anto Pavlovic, Iris Ruf, Helma van den Hurk, Anna F Stevens, Daan van der Vliet, Tom van der Wel, Matthias B Wittwer, Constant A A van Boeckel, Pal Pacher, Andrea G Hohmann, Mario van der Stelt
Monoacylglycerol lipase (MAGL) regulates endocannabinoid 2-arachidonoylglycerol (2-AG) and eicosanoid signalling. MAGL inhibition provides therapeutic opportunities but clinical potential is limited by central nervous system (CNS)-mediated side effects. Here, we report the discovery of LEI-515, a peripherally restricted, reversible MAGL inhibitor, using high throughput screening and a medicinal chemistry programme. LEI-515 increased 2-AG levels in peripheral organs, but not mouse brain. LEI-515 attenuated liver necrosis, oxidative stress and inflammation in a CCl4 -induced acute liver injury model...
December 5, 2023: Nature Communications
https://read.qxmd.com/read/38004445/cancer-cachexia-induced-human-skeletal-muscle-myotube-degeneration-is-prevented-via-cannabinoid-receptor-2-agonism-in-vitro
#49
JOURNAL ARTICLE
John Noone, Mary F Rooney, Marilena Karavyraki, Andrew Yates, Saoirse E O'Sullivan, Richard K Porter
Cachexia syndrome, leading to reduced skeletal muscle and fat mass, is highly prevalent in cancer patients, resulting in further negative implications for these patients. To date, there is no approved therapy for cachexia syndrome. The objective of this study was to establish an in vitro model of cancer cachexia in mature human skeletal muscle myotubes, with the intention of exploiting the cell model to assess potential cachexia therapeutics, specifically cannabinoid related drugs. Having cultured and differentiated primary human muscle myoblasts to mature myotubes, we successfully established two cancer cachexia models using conditioned media (CM) from human colon adenocarcinoma (SW480) and from non-small-cell lung carcinoma (H1299) cultured cells...
November 8, 2023: Pharmaceuticals
https://read.qxmd.com/read/38003528/terpenes-in-cannabis-sativa-inhibit-capsaicin-responses-in-rat-drg-neurons-via-na-k-atpase-activation
#50
JOURNAL ARTICLE
Uma Anand, Praveen Anand, Mikael Hans Sodergren
Terpenes in Cannabis sativa exert analgesic effects, but the mechanisms are uncertain. We examined the effects of 10 terpenes on capsaicin responses in an established model of neuronal hypersensitivity. Adult rat DRG neurons cultured with neurotrophic factors NGF and GDNF were loaded with Fura2AM for calcium imaging, and treated with individual terpenes or vehicle for 5 min, followed by 1 µMol capsaicin. In vehicle treated control experiments, capsaicin elicited immediate and sustained calcium influx. Most neurons treated with terpenes responded to capsaicin after 6-8 min...
November 15, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/38002812/concerns-related-to-the-consequences-of-pediatric-cannabis-use-a-360-degree-view
#51
REVIEW
Flavia Padoan, Chiara Colombrino, Francesca Sciorio, Giorgio Piacentini, Rossella Gaudino, Angelo Pietrobelli, Luca Pecoraro
Cannabis, a plant known for its recreational use, has gained global attention due to its widespread use and addiction potential. Derived from the Cannabis sativa plant, it contains a rich array of phytochemicals concentrated in resin-rich trichomes. The main cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), interact with CB1 and CB2 receptors, influencing various physiological processes. Particularly concerning is its prevalence among adolescents, often driven by the need for social connection and anxiety alleviation...
October 24, 2023: Children
https://read.qxmd.com/read/38002684/cannabis-and-endometriosis-the-roles-of-the-gut-microbiota-and-the-endocannabinoid-system
#52
REVIEW
Toobah Farooqi, Deep Jyoti Bhuyan, Mitchell Low, Justin Sinclair, Mathew Leonardi, Mike Armour
Endometriosis, a chronic condition affecting around 10-14% of women, is challenging to manage, due to its complex pathogenesis and limited treatment options. Research has suggested a potential role of the gut microbiota and the endocannabinoid system in the development and progression of endometriosis. This narrative review aims to explore the role of, and any potential interactions between, the endocannabinoid system (ECS) and the gut microbiota in endometriosis. This review found that both the ECS and microbiota influence endometriosis, with the former regulating inflammation and pain perception and the latter influencing immune responses and hormonal balance...
November 13, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/37998380/elucidation-of-gpr55-associated-signaling-behind-thc-and-lpi-reducing-effects-on-ki67-immunoreactive-nuclei-in-patient-derived-glioblastoma-cells
#53
JOURNAL ARTICLE
Marc Richard Kolbe, Tim Hohmann, Urszula Hohmann, Erik Maronde, Ralph Golbik, Julian Prell, Jörg Illert, Christian Strauss, Faramarz Dehghani
GPR55 is involved in many physiological and pathological processes. In cancer, GPR55 has been described to show accelerating and decelerating effects in tumor progression resulting from distinct intracellular signaling pathways. GPR55 becomes activated by LPI and various plant-derived, endogenous, and synthetic cannabinoids. Cannabinoids such as THC exerted antitumor effects by inhibiting tumor cell proliferation or inducing apoptosis. Besides its effects through CB1 and CB2 receptors, THC modulates cellular responses among others via GPR55...
November 17, 2023: Cells
https://read.qxmd.com/read/37976207/cannabidiol-anticonvulsant-effects-against-lithium-pilocarpine-induced-status-epilepticus-in-male-rats-are-mediated-by-neuroinflammation-modulation-and-cannabinoids-1-cb1-but-not-cb2-and-gaba-a-receptors
#54
JOURNAL ARTICLE
Mahla Masoumi, Mohammad Amin Manavi, Razieh Mohammad Jafari, Alireza Mirzaei, Keshvad Hedayatyanfard, Mohammad Taghi Beigmohammadi, Ahmad Reza Dehpour
Background: Status epilepticus (SE) is a series of seizures that can lead to serious neurological damages. Cannabidiol (CBD) is extracted from the cannabis plant, which has been approved as an antiseizure medication. This study aimed to determine the efficacy of various doses of CBD on lithium-pilocarpine-induced SE in rats and possible involvement of multiple pharmacological pathways. We hypothesized that cannabinoid receptors type 1 (CB1) and CB2, as well as GABAA receptors, might have important roles in the anticonvulsant effects of CBD against SE by its anti-inflammatory effects...
November 17, 2023: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/37970951/tumor-necrosis-factor-%C3%AE-and-agonist-and-antagonists-of-cannabinoid-receptor-type-1-and-type-2-alter-the-immunophenotype-of-stem-cells-from-human-exfoliated-deciduous-teeth
#55
JOURNAL ARTICLE
Marizia Trevizani, Laís Lopardi Leal, João Vitor Paes Rettore, Gilson Costa Macedo, Caio César de Souza Alves, Sandra Bertelli Ribeiro de Castro, Antônio Márcio Resende do Carmo, Silvioney Augusto da Silva, Carlos Magno da Costa Maranduba, Fernando de Sá Silva
OBJECTIVE: To verify the involvement of the endocannabinoid system in the immunomodulatory profile of stem cells from human exfoliated deciduous teeth, in the presence or absence of TNF-α, and agonist and antagonists of CB1 and CB2. METHODS: Stem cells from human exfoliated deciduous teeth were cultured in the presence or absence of an agonist, anandamide, and two antagonists, AM251 and SR144528, of CB1 and CB2 receptors, with or without TNF-α stimulation...
2023: Einstein
https://read.qxmd.com/read/37958673/investigating-the-effects-of-exogenous-and-endogenous-2-arachidonoylglycerol-on-retinal-cb1-cannabinoid-receptors-and-reactive-microglia-in-naive-and-diseased-retina
#56
JOURNAL ARTICLE
Sofia Papadogkonaki, Dimitris Spyridakos, Emmanouela Lapokonstantaki, Nikos Chaniotakis, Alexandros Makriyannis, Michael S Malamas, Kyriaki Thermos
The endocannabinoid system (ECS) is a new target for the development of retinal disease therapeutics, whose pathophysiology involves neurodegeneration and neuroinflammation. The endocannabinoid 2-arachidonoylglycerol (2-AG) affects neurons and microglia by activating CB1/CB2 cannabinoid receptors (Rs). The aim of this study was to investigate the effects of 2-AG on the CB1R expression/downregulation and retinal neurons/reactive microglia, when administered repeatedly (4 d), in three different paradigms. These involved the 2-AG exogenous administration (a) intraperitoneally (i...
October 28, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37931433/canine-immune-cells-express-high-levels-of-cb-1-and-cb-2-cannabinoid-receptors-and-cannabinoid-mediated-alteration-of-canine-cytokine-production-is-vehicle-dependent
#57
JOURNAL ARTICLE
Clare Brown, Matthew Mitsch, Karis Blankenship, Carly Campbell, Mimi Pelanne, Jaylan Sears, Abigail Bell, Alicia K Olivier, Matthew K Ross, Todd Archer, Barbara L F Kaplan
With the increased popularity and societal acceptance of marijuana and cannabidiol (CBD) use in humans, there is an interest in using cannabinoids in veterinary medicine. There have been a few placebo-controlled clinical trials in dogs suggesting that cannabis-containing extracts are beneficial for dogs with inflammatory diseases such as osteoarthritis, and there is growing interest in their immunosuppressive potential for the treatment of immune-mediated diseases. Since cannabinoids exhibit anti-inflammatory and immunosuppressive effects in many species, the purpose of these studies was to examine whether the plant-derived cannabinoids, CBD and Δ9 -tetrahydrocannabinol (THC), would also suppress immune function in canine peripheral blood mononuclear cells (PBMCs)...
October 31, 2023: Veterinary Immunology and Immunopathology
https://read.qxmd.com/read/37926527/involvement-of-cannabinoid-receptors-and-adenosine-a2b-receptor-in-enhanced-migration-of-lung-cancer-a549-cells-induced-by-%C3%AE-ray-irradiation
#58
JOURNAL ARTICLE
Misaki Oyama, Misaki Sakamoto, Kazuki Kitabatake, Kanami Shiina, Daisuke Kitahara, Sohei Onozawa, Keisuke Nishino, Yuka Sudo, Mitsutoshi Tsukimoto
Residual cancer cells after radiation therapy may acquire malignant phenotypes such as enhanced motility and migration ability, and therefore it is important to identify targets for preventing radiation-induced malignancy in order to increase the effectiveness of radiotherapy. G-Protein-coupled receptors (GPCRs) such as adenosine A2B receptor and cannabinoid receptors (CB1, CB2 and GPR55) may be involved, as they are known to have roles in proliferation, invasion, migration and tumor growth. In this study, we investigated the involvement of A2B and cannabinoid receptors in γ-radiation-induced enhancement of cell migration and actin remodeling, as well as the involvement of cannabinoid receptors in cell migration enhancement via activation of A2B receptor in human lung cancer A549 cells...
November 3, 2023: Biological & Pharmaceutical Bulletin
https://read.qxmd.com/read/37903509/in-vitro-cannabinoid-activity-profiling-of-generic-ban-evading-brominated-synthetic-cannabinoid-receptor-agonists-and-their-analogs
#59
JOURNAL ARTICLE
Marie H Deventer, Mattias Persson, Caitlyn Norman, Huiling Liu, Matthew J Connolly, Niamh Nic Daéid, Craig McKenzie, Henrik Gréen, Christophe P Stove
Following the enactment of a generic ban in China in 2021, the synthetic cannabinoid market has been evolving, now encompassing even wider structural diversity. Compounds carrying a brominated core such as ADB-5'Br-BUTINACA (ADMB-B-5Br-INACA) and tail-less analogs, such as ADB-5'Br-INACA (ADMB-5Br-INACA), MDMB-5'Br-INACA, and ADB-INACA (ADMB-INACA), have been detected since late 2021. This study investigated the cannabinoid receptor (CB) activation potential of synthesized (S)-enantiomers of these substances, as well as of two predicted analogs MDMB-5'Br-BUTINACA (MDMB-B-5Br-INACA) and ADB-5'F-BUTINACA (ADMB-B-5F-INACA), using CB1 and CB2 β-arrestin 2 recruitment assays and a CB1 intracellular calcium release assay...
October 30, 2023: Drug Testing and Analysis
https://read.qxmd.com/read/37903029/complex-regional-pain-syndrome-type-i-evidence-for-the-cb1-and-cb2-receptors-immunocontent-and-beneficial-effect-of-local-administration-of-cannabidiol-in-mice
#60
JOURNAL ARTICLE
Alexandre C Buffon, Daiana C Salm, Ana C Heymanns, Nathalia N Donatello, Débora C Martins, Jessica Francine Wichmann, Leandro Giacomello, Verônica V Horewicz, Daniel F Martins, Anna P Piovezan
Introduction: Complex regional pain syndrome type I (CRPS-I) is a debilitating neuropathic painful condition associated with allodynia, hyperalgesia, sudomotor and/or vasomotor dysfunctions, turning investigation of its pathophysiology and new therapeutic strategies into an essential topic. We aim to investigate the impact of ischemia/reperfusion injury on the immunocontent of CB1 and CB2 cannabinoid receptor isoforms in the paws of mice submitted to a chronic postischemia pain (CPIP) model and the effects of local administration of cannabidiol (CBD) on mechanical hyperalgesia...
October 30, 2023: Cannabis and Cannabinoid Research
keyword
keyword
72433
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.